Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 5 min ago
Peer-reviewedCC BYFrontiers in endocrinology

Modified fasting therapy reduces blood pressure independent of weight loss, moderated by age, sex, and HbA1c: a retrospective mediation analysis in dysglycemic patients.

  1. 1Traditional Chinese Medicine Department, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.

Abstract

Objective

To evaluate the effect of modified fasting therapy on blood pressure in dysglycemic adults and to examine the mediating role of weight loss and modifying effects of age, sex, and baseline glycemic status.Methods

This retrospective cohort study included 833 dysglycemic adults who underwent modified fasting therapy. Blood pressure, body weight, and laboratory parameters were measured before and after the intervention. Linear mixed models were used to estimate the effect of fasting on systolic blood pressure (SBP) and diastolic blood pressure (DBP), with adjustment for age, sex, baseline body mass index (BMI), glycosylated hemoglobin (HbA1c), and baseline blood pressure. Mediation analyses were performed using "MEMORE macro" and "wsMed" package to examine the mediating role of weight loss. Interaction terms were included to test effect modification by age, sex, and baseline HbA1c.Results

Fasting therapy significantly reduced SBP (-7.73 mmHg, 95% CI: -8.64 to -6.82, p < 0.001) and DBP (-4.76 mmHg, 95% CI: -5.39 to -4.12, p < 0.001). Mediation analyses revealed that weight loss did not significantly mediate the blood pressure-lowering effect for either SBP (indirect effect: -0.22, p = 0.588) or DBP (indirect effect: 0.09, p = 0.636). The fasting effect was significantly modified by age, sex, and baseline HbA1c, with greater reductions observed in younger patients, males, and those with higher HbA1c levels.Conclusions

Modified fasting therapy significantly reduces blood pressure in dysglycemic adults independent of weight loss. Age, sex, and baseline HbA1c modify the response, suggesting that personalized approaches may optimize the benefits of fasting-based interventions.

Related

  1. Music performance anxiety and restrictive dietary behaviors: a moderated serial mediation model
    Chenghan Zhang, FuQiang Tan, YiHan Feng +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textPsychiatry & mental healthCrossref
  2. A moderated mediation model of the association between parental psychological control and internalizing problems among college students
    Wenmin Li, Jin Meng, Yiqi Liu
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textPsychiatry & mental healthCrossref
  3. Psychological resilience, insomnia, and anxiety among Chinese medical students: a moderated mediation model with academic stress
    Haidong Yang, Yubing Han, Xiaobin Zhang
    BMC Public HealthPeer-reviewedCC BY 4.0Epidemiology & public healthCrossref
  4. Association between frailty and cognitive function in hospitalized older adults: a moderated serial mediation analysis involving functional status, depression, and social support
    Jingrong Dai, Jing Huang, Fang Liu +4
    Frontiers in public healthPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  5. Academic stress, depressive symptoms, and bedtime procrastination: The paradoxical buffering role of eveningness in a moderated chain mediation model
    Yanyan He, Xiaoqian Yu
    PsyArXivPreprintCC BY 4.0Full textPhysiologyOSF
BibTeX
@article{ye2026modified,
  title = {{Modified fasting therapy reduces blood pressure independent of weight loss, moderated by age, sex, and HbA1c: a retrospective mediation analysis in dysglycemic patients.}},
  author = {Ziheng Ye and Jiapan Sun and Tingying Zhang and Jiahao Feng and Dongkai Zeng and Yidan Qin and Li Zhang and Jian Qin and Taoli Liu},
  journal = {Frontiers in endocrinology},
  year = {2026},
  month = oct,
  doi = {10.3389/fendo.2026.1976220},
  url = {https://europepmc.org/article/MED/42908842},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Modified fasting therapy reduces blood pressure independent of weight loss, moderated by age, sex, and HbA1c: a retrospective mediation analysis in dysglycemic patients.
AU  - Ziheng Ye
AU  - Jiapan Sun
AU  - Tingying Zhang
AU  - Jiahao Feng
AU  - Dongkai Zeng
AU  - Yidan Qin
AU  - Li Zhang
AU  - Jian Qin
AU  - Taoli Liu
PY  - 2026
DA  - 2026/10/07
JO  - Frontiers in endocrinology
DO  - 10.3389/fendo.2026.1976220
UR  - https://europepmc.org/article/MED/42908842
AB  - Objective  To evaluate the effect of modified fasting therapy on blood pressure in dysglycemic adults and to examine the mediating role of weight loss and modifying effects of age, sex, and baseline glycemic status.Methods  This retrospective cohort study included 833 dysglycemic adults who underwent modified fasting therapy. Blood pressure, body weight, and laboratory parameters were measured before and after the intervention. Linear mixed models were used to estimate the effect of fasting on systolic blood pressure (SBP) and diastolic blood pressure (DBP), with adjustment for age, sex, baseline body mass index (BMI), glycosylated hemoglobin (HbA1c), and baseline blood pressure. Mediation analyses were performed using "MEMORE macro" and "wsMed" package to examine the mediating role of weight loss. Interaction terms were included to test effect modification by age, sex, and baseline HbA1c.Results  Fasting therapy significantly reduced SBP (-7.73 mmHg, 95% CI: -8.64 to -6.82, p < 0.001) and DBP (-4.76 mmHg, 95% CI: -5.39 to -4.12, p < 0.001). Mediation analyses revealed that weight loss did not significantly mediate the blood pressure-lowering effect for either SBP (indirect effect: -0.22, p = 0.588) or DBP (indirect effect: 0.09, p = 0.636). The fasting effect was significantly modified by age, sex, and baseline HbA1c, with greater reductions observed in younger patients, males, and those with higher HbA1c levels.Conclusions  Modified fasting therapy significantly reduces blood pressure in dysglycemic adults independent of weight loss. Age, sex, and baseline HbA1c modify the response, suggesting that personalized approaches may optimize the benefits of fasting-based interventions.
SN  - 1664-2392
ER  -